Galapagos and Blood Centers of America collaboration

Galapagos and Blood Centers of America announce strategic collaboration to accelerate Galapagos’ decentralized CAR-T manufacturing network in the U.S.

  • BCA’s national network of blood centers will provide decentralized manufacturing services for
    Galapagos’ CAR-T product candidates, close to cancer treatment centers
  • Collaboration enables rapid deployment of Galapagos’ decentralized CAR-T platform across the U.S., improving patient access to potentially life-saving CAR-T treatments
  • Important milestone for Galapagos’ U.S. expansion strategy, supporting upcoming pivotal trials and potential future commercial manufacturing of CAR-T therapies
  • Complements existing collaborations with Galapagos’ other manufacturing partners